Incyte Corporation

Our deaminative cross-coupling used redox-active esters from amino acids.

Endo International plc (Dublin, Ireland). Acquired by Pharma & Co. (2024). Supprelin, Xiaflex, Lidoderm. Generic sterile injectables. Par Pharmaceutical generics. Specialty: urology, orthopedics.

GE Healthcare Life Sciences (now Cytiva). Chromatography resins, cell culture media, filtration. Contrast agents (Omnipaque, Visipaque). Protein A chromatography. Bioprocess manufacturing.

Navin Fluorine International CRAMS Division (Surat, India). Fluorochemicals CRAMS for global pharma. HFCs (R-134a, R-125), HFOs. Fine chemicals & fluoro-intermediates. Contract research and manufacturing.

Reckitt Benckiser Group plc (Slough, UK). 2024 revenue ~£14.2B. Hygiene, health, nutrition brands: Dettol, Lysol, Mucinex, Nurofen, Enfamil. Surface chemistry, disinfection chemistry.

Our NBO analysis showed strong σ-donation from the NHC ligand.

IMCD N.V. (Rotterdam, Netherlands) — global specialty chemicals and food ingredients distributor. 2024 revenue ~€4.8B. 45K+ products. Pharma, food, personal care, coatings, synthesis. 3.6K employees. Acquisitions in 15+ countries.

The xylanase showed optimal activity at 70°C and pH 9 — ideal for paper bleaching.

The viral inactivation step at pH 3.5 for 60 min showed >5 log10 clearance.

安徽海螺水泥股份有限公司(芜湖)。2024年营收约1800亿。中国最大水泥生产商。水泥化学: 硅酸钙、铝酸钙。碳捕集(CCUS): 5万吨/年CO2捕集装置。水泥窑协同处置。新能源: 光伏+储能。

滨海(江苏)新材料。锂电池电解液: LiPF6、溶剂(EC, DMC, EMC, DEC)、添加剂(VC, FEC)。湿电子化学品: 电子级氢氟酸、双氧水。半导体和新能源材料双业务。

Medtronic plc (Dublin, Ireland / Minneapolis, MN). Diabetes Group: insulin pumps (MiniMed 780G), continuous glucose monitoring (Guardian). 2024 diabetes revenue ~$2.5B. Drug delivery chemistry, biosensors.

The magnetoresistive sensor detected ppb-level target molecules.

The hERG channel inhibition IC50 was >30 μM — no cardiac liability.

Cell-free protein synthesis achieved gram-per-liter titers for our target protein.

Bayer AG Pharmaceuticals Division (Berlin). 2024 revenue ~€18B. Eylea (aflibercept), Xarelto, Aspirin. Radiology: Ultravist, Gadovist. Cell & Gene Therapy. Women's health: Mirena, Kyleena.

Impressive R&D pipeline. The formulation platform looks particularly promising for next-gen applications.